1.Response: Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased beta-Cell Function Similar to Impaired Glucose Tolerance (Diabetes Metab J 2015;39:147-53).
Tae Jung OH ; Se Hee MIN ; Chang Ho AHN ; Eun Ky KIM ; Soo Heon KWAK ; Hye Seung JUNG ; Kyong Soo PARK ; Young Min CHO
Diabetes & Metabolism Journal 2015;39(3):270-271
No abstract available.
Blood Glucose*
;
Glucose*
3.Performance Evaluation of the ARKRAY ADAMS Bridge System Comprising Glucose GA-1171 and HbA1c HA-8180 Analyzers.
Geehay HONG ; Soo Youn LEE ; Hyung Doo PARK
Laboratory Medicine Online 2014;4(4):179-186
BACKGROUND: In diabetic patients, both glucose and hemoglobin A1c (HbA1c) concentrations are frequently measured to monitor glycemic control. We examined the analytical performance of the recently developed, automated, ADAMS bridge system (Arkray, Inc., Japan) consisting of the ADAMS glucose GA-1171 and the ADAMS HbA1c HA-8180 analyzers, which allows the consecutive measurement of glucose and HbA1c concentrations. METHODS: We evaluated precision, linearity, carry-over, effects of hematocrit, and turnaround time. Method comparison was conducted between GA-1171 and UniCel DxC 800 (Beckman Coulter, Inc., USA) and Synchron CX3 Delta (Beckman Coulter) for glucose, and between HA-8180 and HLC-723 G8 (Tosoh Bioscience, Inc., Japan) for HbA1c measurements. RESULTS: Total precision (% CV) in measuring high and low level controls was 1.11% and 1.21% for glucose using GA-1171, and 0.86% and 1.3% for HbA1c using HA-8180, respectively. In the linearity test, R2 was 0.9997, 0.9991 and 0.9973 when measuring plasma glucose (58-532 mg/dL), whole blood glucose (74-401 mg/dL), and HbA1c concentrations (4.7-14.7%), respectively. Good correlation was observed between GA-1171 and DxC 800 (r=0.9987), and between HA-8180 and HLC-723 G8 (r=0.9980). Carry-over effect was less than 0.5% for glucose and HbA1c. Turnaround time was reduced from 7 min (CX3 Delta) and 1.43 min (HLC-723 G8) to 2.16 min (GA-1171) and 1.54 min (HA-8180), respectively, when whole blood glucose and HbA1c concentrations were measured consecutively by the ADAMS bridge system. CONCLUSIONS: The ADAMS bridge system had a simple operating procedure and showed an adequate performance and a rapid turnaround time.
Blood Glucose
;
Glucose*
;
Hematocrit
;
Humans
4.Situation of lipemia disorder in patients with reduced glucose toleration
Journal of Practical Medicine 2002;435(11):36-38
Study on 50 patients (male: 12, female: 38), between the ages of 72 and 40, with hypertension (62% of patients), obesity (60%) in which abdominal obesity (78%) was carried out in Bach Mai Hospital during July 2000- March 2001. The results found that the lipemia disorder frequently occurred in patients with reduced glucose toleration according to the classification of Fredrichson (type IV). 69% patients with the reduced glucose toleration had a lipemia disorder accompanying with hypertension. The risk of hypertension among these patients was higher 6.7 times than this among patients without the lipemia disorder. 93% patients with the reduced glucose toleration and obesity had a lipemia disorder. This rate in the patients with abnormal obesity was 97%; 100% of patients with the reduced glucose toleration had signs of coronary insufficiency
Glucose
;
Lipoprotein Lipase
;
Blood Glucose
5.Blood Glucose Measurement: Is Serum Equal to Plasma?.
Diabetes & Metabolism Journal 2016;40(5):365-366
No abstract available.
Blood Glucose*
;
Plasma*
6.Comparison of blood glucose concentrations from capillaries and veins in SMBG.
Journal of Korean Academy of Nursing 1998;28(1):143-147
No abstract available.
Blood Glucose*
;
Capillaries*
;
Veins*
7.Prognostic significance of initial blood glucose level in near-drowning.
Journal of the Korean Child Neurology Society 1993;1(2):131-136
No abstract available.
Blood Glucose*
;
Near Drowning*
8.Association between estimated blood glucose levels and glycated hemoglobin levels.
The Korean Journal of Internal Medicine 2016;31(3):457-460
No abstract available.
Blood Glucose*
;
Hemoglobin A, Glycosylated*
9.Blood glucose level after febrile convulsion.
Mohamed Amin GHOBADIFAR ; Naser HONAR ; Parisa JOOYA ; Fatemeh HASSANI
Korean Journal of Pediatrics 2016;59(3):153-154
No abstract available.
Blood Glucose*
;
Seizures, Febrile*
10.Blood glucose level after febrile convulsion.
Mohamed Amin GHOBADIFAR ; Naser HONAR ; Parisa JOOYA ; Fatemeh HASSANI
Korean Journal of Pediatrics 2016;59(3):153-154
No abstract available.
Blood Glucose*
;
Seizures, Febrile*